{"id":"dihydroartemisinin-plus-piperaquine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL539666","moleculeType":"Small molecule","molecularWeight":"633.52"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Dihydroartemisinin works by generating free radicals that damage the malaria parasite's cell membrane, ultimately leading to its death. Piperaquine, on the other hand, targets the parasite's liver stages and prevents its re-emergence. This combination therapy is effective against both the blood and liver stages of the malaria parasite.","oneSentence":"Dihydroartemisinin is a derivative of artemisinin that kills malaria parasites by generating free radicals, while piperaquine acts as a blood schizonticide.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:26.380Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Uncomplicated malaria"},{"name":"Severe malaria"}]},"trialDetails":[{"nctId":"NCT07470424","phase":"PHASE1","title":"A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2026-06-01","conditions":"Malaria","enrollment":24},{"nctId":"NCT07403643","phase":"PHASE4","title":"Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria","status":"NOT_YET_RECRUITING","sponsor":"Curtin University","startDate":"2026-04","conditions":"Uncomplicated Malaria","enrollment":60},{"nctId":"NCT07389057","phase":"NA","title":"Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana","status":"RECRUITING","sponsor":"Noguchi Memorial Institute for Medical Research","startDate":"2023-11-01","conditions":"Malaria Asymptomatic Parasitaemia, Malaria Falciparum, Malaria Infection","enrollment":9000},{"nctId":"NCT07362498","phase":"","title":"Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya","status":"COMPLETED","sponsor":"Strathmore University","startDate":"2020-06-01","conditions":"Malaria Falciparum","enrollment":316},{"nctId":"NCT07322068","phase":"PHASE4","title":"Perennial Malaria Chemoprevention in the Malaria Vaccine Era","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-09","conditions":"Malaria, Falciparum","enrollment":1290},{"nctId":"NCT06068530","phase":"PHASE4","title":"Mass Vaccine and Drug Administration, Bangladesh","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-02-15","conditions":"Plasmodium Falciparum Malaria","enrollment":10000},{"nctId":"NCT04009343","phase":"PHASE2, PHASE3","title":"Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2019-06-19","conditions":"Uncomplicated Falciparum Malaria","enrollment":182},{"nctId":"NCT07281443","phase":"NA","title":"MDA and Targeted Control Against Plasmodium Carriage in the Sahel","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut de Recherche pour le Developpement","startDate":"2024-09-23","conditions":"Malaria, Falciparum, Malaria, Asymptomatic Parasitaemia","enrollment":18000},{"nctId":"NCT06962319","phase":"PHASE3","title":"Safety of Antimalarials in the FIRst trimEster","status":"RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2025-09-30","conditions":"Malaria, Pregnancy, Malaria, Antepartum, Malaria (Uncomplicated)","enrollment":1510},{"nctId":"NCT06083688","phase":"PHASE4","title":"Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi","status":"ACTIVE_NOT_RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2024-10-14","conditions":"Malaria,Falciparum, Anemia in Children","enrollment":1000},{"nctId":"NCT05343312","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2022-03-16","conditions":"Malaria","enrollment":870},{"nctId":"NCT06870344","phase":"NA","title":"IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-03-12","conditions":"Malaria Infection, Malaria Falciparum","enrollment":36000},{"nctId":"NCT07082205","phase":"PHASE3","title":"Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge","status":"RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2025-05-02","conditions":"Malaria, Severe Malaria, Severe Anaemia","enrollment":398},{"nctId":"NCT05252845","phase":"PHASE2","title":"Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2023-01-04","conditions":"Malaria,Falciparum","enrollment":127},{"nctId":"NCT05426434","phase":"PHASE3","title":"Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Menzies School of Health Research","startDate":"2022-08-31","conditions":"Malaria, Malaria in Pregnancy, Pregnancy Related","enrollment":1172},{"nctId":"NCT05788094","phase":"PHASE4","title":"ACT vs CQ With Tafenoquine for P. Vivax Mono-infection","status":"RECRUITING","sponsor":"Shoklo Malaria Research Unit","startDate":"2023-06-26","conditions":"Malaria, Malaria, Vivax, Plasmodium Vivax Malaria","enrollment":606},{"nctId":"NCT06973200","phase":"","title":"Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso","status":"COMPLETED","sponsor":"Centre MURAZ/Institut National de Santé Publique","startDate":"2024-11-11","conditions":"Schistosomiasis in Children, Soil Transmitted Helminth (STH) Infections, Malaria Infection","enrollment":300},{"nctId":"NCT06516042","phase":"PHASE3","title":"Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia","status":"ACTIVE_NOT_RECRUITING","sponsor":"PATH","startDate":"2024-08-21","conditions":"Plasmodium Falciparum, Malaria","enrollment":10350},{"nctId":"NCT04978272","phase":"PHASE3","title":"Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Grant Dorsey, M.D, Ph.D.","startDate":"2022-02-08","conditions":"Malaria","enrollment":924},{"nctId":"NCT06347471","phase":"PHASE4","title":"The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy","status":"RECRUITING","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2024-05-28","conditions":"Falciparum; Malaria","enrollment":120},{"nctId":"NCT06225297","phase":"PHASE4","title":"Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, Senegal","status":"SUSPENDED","sponsor":"PATH","startDate":"2024-01-19","conditions":"Malaria","enrollment":4600},{"nctId":"NCT04816461","phase":"PHASE4","title":"Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates","status":"COMPLETED","sponsor":"Institut de Recherche en Sciences de la Sante, Burkina Faso","startDate":"2021-07-07","conditions":"Malaria, Malaria Prophylaxis, Mass Testing and Treatment","enrollment":526},{"nctId":"NCT02163447","phase":"PHASE3","title":"Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants","status":"COMPLETED","sponsor":"Grant Dorsey, M.D, Ph.D.","startDate":"2014-06-23","conditions":"Malaria","enrollment":300},{"nctId":"NCT03671109","phase":"PHASE3","title":"Improving Maternal heAlth by Reducing Malaria in African HIV Women","status":"COMPLETED","sponsor":"Barcelona Institute for Global Health","startDate":"2019-09-18","conditions":"Malaria, HIV/AIDS, Pregnancy Related","enrollment":666},{"nctId":"NCT04661579","phase":"PHASE2","title":"Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy","status":"COMPLETED","sponsor":"PATH","startDate":"2020-11-06","conditions":"Plasmodium Falciparum","enrollment":620},{"nctId":"NCT04864444","phase":"NA","title":"Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-06-19","conditions":"Malaria,Falciparum, Malaria","enrollment":10715},{"nctId":"NCT03178643","phase":"PHASE4","title":"Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-01-23","conditions":"Malaria,Falciparum","enrollment":246},{"nctId":"NCT05294406","phase":"PHASE4","title":"Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2022-02-07","conditions":"Malaria in Pregnancy","enrollment":2128},{"nctId":"NCT04767217","phase":"PHASE4","title":"Malaria Therapeutic Efficacy Study, Rwanda","status":"COMPLETED","sponsor":"Jhpiego","startDate":"2021-06-14","conditions":"Uncomplicated Malaria","enrollment":528},{"nctId":"NCT05946642","phase":"PHASE3","title":"Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2023-07-15","conditions":"Malaria","enrollment":13000},{"nctId":"NCT04844099","phase":"PHASE3","title":"Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2021-04-09","conditions":"Sickle Cell Anemia in Children, Malaria","enrollment":723},{"nctId":"NCT06036030","phase":"PHASE2","title":"Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua","status":"COMPLETED","sponsor":"Syamsudin Abdillah,Ph.D, Pharm D","startDate":"2019-01-11","conditions":"Malaria,Falciparum, Malaria, Vivax, Malaria","enrollment":50},{"nctId":"NCT04158713","phase":"PHASE3","title":"Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2019-11-11","conditions":"Pregnancy; HIV; Malaria","enrollment":898},{"nctId":"NCT05980156","phase":"PHASE4","title":"Comparing Chemoprevention Drugs for School-based Malaria Control","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2023-02-13","conditions":"Malaria,Falciparum, Anemia in Children","enrollment":646},{"nctId":"NCT03208907","phase":"PHASE3","title":"DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil","status":"COMPLETED","sponsor":"Fundação de Medicina Tropical Dr. Heitor Vieira Dourado","startDate":"2018-07-05","conditions":"Malaria, Vivax, Therapeutics","enrollment":419},{"nctId":"NCT05874869","phase":"NA","title":"Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania","status":"COMPLETED","sponsor":"Richard Mwaiswelo","startDate":"2020-07-01","conditions":"Malaria, Chemoprophylaxis, Underfive Children","enrollment":13800},{"nctId":"NCT04189744","phase":"PHASE3","title":"The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-12-15","conditions":"Pregnancy Malaria, Bacterial Vaginoses, Trichomonas Vaginitis","enrollment":5436},{"nctId":"NCT05829187","phase":"PHASE2","title":"Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency","status":"COMPLETED","sponsor":"Syamsudin Abdillah,Ph.D, Pharm D","startDate":"2022-11-01","conditions":"Uncomplicated Plasmodium Falciparum","enrollment":36},{"nctId":"NCT04147546","phase":"PHASE3","title":"Additional Screening With Sensitives RDTs and Malaria","status":"COMPLETED","sponsor":"Institut de Recherche en Sciences de la Sante, Burkina Faso","startDate":"2020-08-31","conditions":"Plasmodium Falciparum Malaria, Malaria Diagnosis","enrollment":340},{"nctId":"NCT05244954","phase":"PHASE4","title":"Comparing Chemoprevention Approaches for School-based Malaria Control","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2022-02-01","conditions":"Malaria,Falciparum, Anemia in Children","enrollment":746},{"nctId":"NCT03355664","phase":"PHASE3","title":"Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2018-03-19","conditions":"Malaria, Falciparum","enrollment":310},{"nctId":"NCT03208179","phase":"PHASE3","title":"Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2018-03-29","conditions":"Pregnancy, Malaria in Pregnancy, Malaria","enrollment":4680},{"nctId":"NCT04609098","phase":"PHASE2","title":"Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2020-10-29","conditions":"Malaria, Falciparum","enrollment":80},{"nctId":"NCT05052502","phase":"NA","title":"Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand","status":"UNKNOWN","sponsor":"University of California, San Francisco","startDate":"2020-11-01","conditions":"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria","enrollment":49118},{"nctId":"NCT04053907","phase":"NA","title":"P. Falciparum Infection Dynamics and Transmission to Inform Elimination","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-08-15","conditions":"Malaria","enrollment":4000},{"nctId":"NCT03576313","phase":"PHASE3","title":"Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2018-08-11","conditions":"Malaria","enrollment":4939},{"nctId":"NCT02802813","phase":"PHASE1, PHASE2","title":"P.Vivax Treatment Trial","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-06-14","conditions":"Plasmodium Vivax","enrollment":41},{"nctId":"NCT04844905","phase":"PHASE3","title":"Adjunctive Ivermectin Mass Drug Administration for Malaria Control","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-05-03","conditions":"Malaria,Falciparum, Neglected Tropical Diseases, Strongyloidiasis","enrollment":24000},{"nctId":"NCT05060198","phase":"NA","title":"Therapeutic Efficacy Study of AL and DP in Western Kenya","status":"COMPLETED","sponsor":"Kenya Medical Research Institute","startDate":"2016-06-17","conditions":"Malaria,Falciparum","enrollment":340},{"nctId":"NCT02315690","phase":"PHASE3","title":"Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-09","conditions":"Malaria","enrollment":4000},{"nctId":"NCT03009526","phase":"PHASE3","title":"Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi","status":"COMPLETED","sponsor":"Kamuzu University of Health Sciences","startDate":"2017-01-17","conditions":"Malaria, Pregnancy","enrollment":602},{"nctId":"NCT04160026","phase":"PHASE4","title":"Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2019-11-11","conditions":"Malaria in Pregnancy, Adherence, Treatment","enrollment":1600},{"nctId":"NCT02793622","phase":"PHASE3","title":"Prevention of Malaria in HIV-uninfected Pregnant Women and Infants","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-09","conditions":"Malaria","enrollment":782},{"nctId":"NCT01280162","phase":"NA","title":"Malaria Active Epidemiology and Treatment Study","status":"COMPLETED","sponsor":"Armed Forces Research Institute of Medical Sciences, Thailand","startDate":"2010-09","conditions":"Malaria","enrollment":222},{"nctId":"NCT02653898","phase":"PHASE4","title":"Malaria Elimination Pilot Study in Military Forces in Cambodia","status":"UNKNOWN","sponsor":"Armed Forces Research Institute of Medical Sciences, Thailand","startDate":"2016-01","conditions":"Malaria, Parasitic Diseases","enrollment":1050},{"nctId":"NCT04660110","phase":"PHASE3","title":"Household-level Impact of IPT of Malaria in Schoolchildren","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2021-01-28","conditions":"Malaria","enrollment":1500},{"nctId":"NCT02614404","phase":"PHASE1","title":"Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria","status":"COMPLETED","sponsor":"HuLow","startDate":"2015-11","conditions":"Plasmodium Falciparum Malaria","enrollment":15},{"nctId":"NCT02654912","phase":"PHASE4","title":"Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration","status":"COMPLETED","sponsor":"PATH","startDate":"2016-02","conditions":"Malaria","enrollment":8682},{"nctId":"NCT02329301","phase":"NA","title":"Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia","status":"COMPLETED","sponsor":"PATH","startDate":"2014-09","conditions":"Malaria, Malaria, Falciparum","enrollment":2430},{"nctId":"NCT02878200","phase":"NA","title":"RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2016-11-04","conditions":"Malaria","enrollment":2236},{"nctId":"NCT01872702","phase":"NA","title":"Targeted Chemo-elimination (TCE) of Malaria","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2013-04","conditions":"Plasmodium Falciparum Malaria","enrollment":8000},{"nctId":"NCT02802501","phase":"PHASE3","title":"Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-04-08","conditions":"Malaria, Vivax","enrollment":150},{"nctId":"NCT02671175","phase":"PHASE3","title":"Post-discharge Malaria Chemoprevention(PMC) Study","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2016-05-20","conditions":"Malaria, Severe Anemia","enrollment":1049},{"nctId":"NCT04049916","phase":"PHASE2, PHASE3","title":"Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-09-12","conditions":"Malaria,Falciparum","enrollment":100},{"nctId":"NCT02612545","phase":"PHASE1","title":"Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-11-20","conditions":"Acute Falciparum Malaria","enrollment":216},{"nctId":"NCT01845701","phase":"PHASE3","title":"Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon","status":"COMPLETED","sponsor":"University of Yaounde 1","startDate":"2010-03","conditions":"Malaria","enrollment":720},{"nctId":"NCT02110784","phase":"PHASE2","title":"Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria","status":"TERMINATED","sponsor":"Alfasigma S.p.A.","startDate":"2014-06-18","conditions":"Malaria, Vivax","enrollment":27},{"nctId":"NCT02511353","phase":"PHASE2","title":"Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2015-07","conditions":"Malaria","enrollment":141},{"nctId":"NCT02001428","phase":"NA","title":"Malaria in Early Life Study","status":"COMPLETED","sponsor":"Gadjah Mada University","startDate":"2014-07-21","conditions":"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria","enrollment":757},{"nctId":"NCT02453308","phase":"PHASE2, PHASE3","title":"A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2015-08","conditions":"Malaria, Falciparum","enrollment":1110},{"nctId":"NCT00682578","phase":"PHASE3","title":"A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2007-07","conditions":"Uncomplicated Falciparum Malaria, Vivax Malaria","enrollment":1086},{"nctId":"NCT01838902","phase":"PHASE3","title":"Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-08","conditions":"Malaria","enrollment":467},{"nctId":"NCT01930331","phase":"PHASE4","title":"Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO","status":"COMPLETED","sponsor":"Ifakara Health Institute","startDate":"2014-01-07","conditions":"Plasmodium Falciparum, Malaria, Falciparum","enrollment":60},{"nctId":"NCT02914145","phase":"NA","title":"Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2015-11","conditions":"Malaria","enrollment":240502},{"nctId":"NCT02721420","phase":"PHASE3","title":"Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawi","status":"UNKNOWN","sponsor":"Kamuzu University of Health Sciences","startDate":"2016-03-24","conditions":"Malaria, Severe Anemia","enrollment":375},{"nctId":"NCT02940756","phase":"PHASE4","title":"Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo","status":"COMPLETED","sponsor":"Ministry of Public Health, Democratic Republic of the Congo","startDate":"2017-03-15","conditions":"Malaria","enrollment":1615},{"nctId":"NCT02590627","phase":"PHASE4","title":"In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure","status":"COMPLETED","sponsor":"National Institute for Medical Research, Tanzania","startDate":"2014-05","conditions":"Malaria","enrollment":509},{"nctId":"NCT02721186","phase":"NA","title":"Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar","status":"COMPLETED","sponsor":"Ulrika Morris","startDate":"2016-04-30","conditions":"Malaria, Plasmodium Infections","enrollment":22500},{"nctId":"NCT02184637","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-07-31","conditions":"Malaria, Vivax","enrollment":120},{"nctId":"NCT02788864","phase":"PHASE4","title":"Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2016-05-20","conditions":"Malaria","enrollment":150},{"nctId":"NCT01669941","phase":"PHASE4","title":"Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya","status":"COMPLETED","sponsor":"Kenya Medical Research Institute","startDate":"2012-08","conditions":"Pregnancy, Malaria","enrollment":1546},{"nctId":"NCT02353494","phase":"","title":"Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria","status":"COMPLETED","sponsor":"Menzies School of Health Research","startDate":"2015-03","conditions":"Plasmodium Falciparum Infection, Plasmodium Vivax Infection","enrollment":130},{"nctId":"NCT00561899","phase":"PHASE2, PHASE3","title":"Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Children","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2007-08","conditions":"Malaria","enrollment":1295},{"nctId":"NCT02831023","phase":"PHASE2","title":"Phase 2 Efficacy Study of Primaquine and Methylene Blue","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-07","conditions":"Malaria","enrollment":80},{"nctId":"NCT02987270","phase":"PHASE3","title":"Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya","status":"COMPLETED","sponsor":"Simon Kariuki","startDate":"2013-04","conditions":"Malaria,Falciparum","enrollment":90000},{"nctId":"NCT02974348","phase":"PHASE3","title":"Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa","status":"COMPLETED","sponsor":"University of Bamenda","startDate":"2013-01","conditions":"Drug Resistant Malaria Due to Plasmodium Falciparum","enrollment":300},{"nctId":"NCT01992900","phase":"PHASE2","title":"A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria","status":"COMPLETED","sponsor":"sigma-tau i.f.r. S.p.A.","startDate":"2013-11","conditions":"Malaria,Falciparum","enrollment":300},{"nctId":"NCT02654730","phase":"PHASE2, PHASE3","title":"Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia","status":"TERMINATED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2015-12","conditions":"Malaria","enrollment":61},{"nctId":"NCT02434952","phase":"PHASE4","title":"Safety and Tolerability of Low Dose Primaquine","status":"COMPLETED","sponsor":"Malaria Consortium","startDate":"2014-10","conditions":"Malaria, Falciparum, G6PD Deficiency","enrollment":109},{"nctId":"NCT01640574","phase":"PHASE3","title":"Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2012-02","conditions":"Vivax Malaria","enrollment":680},{"nctId":"NCT00852423","phase":"PHASE3","title":"Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2010-06","conditions":"Malaria in Pregnancy","enrollment":3428},{"nctId":"NCT02259426","phase":"PHASE3","title":"Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2014-10","conditions":"Malaria, Asymptomatic Malaria, Plasmodium Falciparum","enrollment":120},{"nctId":"NCT02604966","phase":"PHASE4","title":"P. Falciparum Resistance to Artemisinin in Vietnam","status":"UNKNOWN","sponsor":"National Institute of Malariology, Parasitology and Entomology, Vietnam","startDate":"2015-04","conditions":"Drug Resistant Malaria Due to Plasmodium Falciparum","enrollment":120},{"nctId":"NCT02009215","phase":"PHASE4","title":"School-Based Treatment With ACT to Reduce Transmission","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2014-02","conditions":"Malaria","enrollment":10746},{"nctId":"NCT01651416","phase":"PHASE4","title":"Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana","status":"COMPLETED","sponsor":"Centre for Global Health Research, Ghana","startDate":"2012-07","conditions":"Malaria, Anaemia","enrollment":2400},{"nctId":"NCT02325180","phase":"PHASE4","title":"Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2015-01","conditions":"Malaria, Falciparum","enrollment":338},{"nctId":"NCT02118090","phase":"PHASE4","title":"Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:","status":"COMPLETED","sponsor":"Institut Pasteur, Cambodia","startDate":"2014-05","conditions":"Vivax Malaria","enrollment":73},{"nctId":"NCT02199951","phase":"","title":"Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania","status":"UNKNOWN","sponsor":"INDEPTH Network","startDate":"2013-09","conditions":"Malaria","enrollment":10000},{"nctId":"NCT00393679","phase":"PHASE3","title":"Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2007-07","conditions":"Fever, Malaria","enrollment":4112},{"nctId":"NCT01878357","phase":"PHASE4","title":"Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2013-06","conditions":"Malaria","enrollment":1488}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Duo cotexcin"],"phase":"phase_3","status":"active","brandName":"dihydroartemisinin plus piperaquine","genericName":"dihydroartemisinin plus piperaquine","companyName":"London School of Hygiene and Tropical Medicine","companyId":"london-school-of-hygiene-and-tropical-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dihydroartemisinin is a derivative of artemisinin that kills malaria parasites by generating free radicals, while piperaquine acts as a blood schizonticide. Used for Uncomplicated malaria, Severe malaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}